Chronic Conditions
Teladoc-Livongo: The $18.5 Billion Valuation Trap & AI Lessons
The healthcare AI landscape is rife with innovation, promising transformative shifts in patient care and operational…
Chronic Conditions
Chronic Conditions
Teladoc’s Billion-Dollar Blunder: Validating Clinical-First AI
The healthcare AI landscape is littered with cautionary tales, but few resonate with the stark clarity…
Chronic Conditions
Teladoc-Livongo: The $13.7 Billion Impairment & Clinical Validation Gap
The acquisition of Livongo by Teladoc in 2020 for an eye-watering $18.5 billion was heralded as…
Chronic Conditions
Teladoc’s Billion Dollar Blunder: The Clinical Validation Gap
The $18.5 billion merger of Teladoc and Livongo in 2020 was heralded as a transformative moment…
Chronic Conditions
Digital Health ROI Leaders: Hinge, Sword, Spring Benchmarked
The landscape of digital health investment is increasingly defined by demonstrable return on investment (ROI), shifting…